<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37816478</PMID><DateCompleted><Year>2023</Year><Month>12</Month><Day>16</Day></DateCompleted><DateRevised><Year>2023</Year><Month>12</Month><Day>16</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1872-8057</ISSN><JournalIssue CitedMedium="Internet"><Volume>579</Volume><PubDate><Year>2024</Year><Month>Jan</Month><Day>01</Day></PubDate></JournalIssue><Title>Molecular and cellular endocrinology</Title><ISOAbbreviation>Mol Cell Endocrinol</ISOAbbreviation></Journal><ArticleTitle>Low growth hormone secretion associated with post-acute sequelae SARS-CoV-2 infection (PASC) neurologic symptoms: A case-control pilot study.</ArticleTitle><Pagination><StartPage>112071</StartPage><MedlinePgn>112071</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.mce.2023.112071</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0303-7207(23)00222-8</ELocationID><Abstract><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">To determine if patients that develop lingering neurologic symptoms of fatigue and "brain fog" after initial recovery from coronavirus disease 2019 (COVID-19) have persistent low growth hormone (GH) secretion as seen in other conditions with similar symptom etiology.</AbstractText><AbstractText Label="DESIGN" NlmCategory="METHODS">In this case-control observational pilot study, patients reporting lingering neurologic post-acute sequelae of SARS-CoV-2 (PASC, n&#xa0;=&#xa0;10) symptoms at least 6 months after initial infection were compared to patients that recovered from COVID-19 without lingering symptoms (non-PASC, n&#xa0;=&#xa0;13). We compared basic blood chemistry and select metabolites, lipids, hormones, inflammatory markers, and vitamins between groups. PASC and non-PASC subjects were tested for neurocognition and GH secretion, and given questionnaires to assess symptom severity. PASC subjects were also tested for glucose tolerance and adrenal function.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">PASC subjects reported significantly worse fatigue, sleep quality, depression, quality of life, and gastrointestinal discomfort compared to non-PASC. Although PASC subjects self-reported poor mental resilience, cognitive testing did not reveal significant differences between groups. Neurologic PASC symptoms were not linked to inflammatory markers or adrenal insufficiency, but were associated with reduced growth hormone secretion.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Neurologic PASC symptoms are associated with gastrointestinal discomfort and persistent disruption of GH secretion following recovery from acute COVID-19. (www.</AbstractText><AbstractText Label="CLINICALTRIALS" NlmCategory="RESULTS">gov; NCT04860869).</AbstractText><CopyrightInformation>Copyright &#xa9; 2023 Elsevier B.V. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Wright</LastName><ForeName>Traver J</ForeName><Initials>TJ</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, The University of Texas Medical Branch, Galveston, Texas, 77555, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pyles</LastName><ForeName>Richard B</ForeName><Initials>RB</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, The University of Texas Medical Branch, Galveston, Texas, 77555, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sheffield-Moore</LastName><ForeName>Melinda</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, The University of Texas Medical Branch, Galveston, Texas, 77555, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Deer</LastName><ForeName>Rachel R</ForeName><Initials>RR</Initials><AffiliationInfo><Affiliation>Department of Nutrition, Metabolism, and Rehabilitation Sciences, The University of Texas Medical Branch, Galveston, Texas, 77555, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Randolph</LastName><ForeName>Kathleen M</ForeName><Initials>KM</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, The University of Texas Medical Branch, Galveston, Texas, 77555, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>McGovern</LastName><ForeName>Kristen A</ForeName><Initials>KA</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, The University of Texas Medical Branch, Galveston, Texas, 77555, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Danesi</LastName><ForeName>Christopher P</ForeName><Initials>CP</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, The University of Texas Medical Branch, Galveston, Texas, 77555, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gilkison</LastName><ForeName>Charles R</ForeName><Initials>CR</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, The University of Texas Medical Branch, Galveston, Texas, 77555, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ward</LastName><ForeName>Weston W</ForeName><Initials>WW</Initials><AffiliationInfo><Affiliation>School of Medicine, The University of Texas Medical Branch, Galveston, Texas, 77555, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vargas</LastName><ForeName>Jayson A</ForeName><Initials>JA</Initials><AffiliationInfo><Affiliation>School of Medicine, The University of Texas Medical Branch, Galveston, Texas, 77555, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Armstrong</LastName><ForeName>Peyton A</ForeName><Initials>PA</Initials><AffiliationInfo><Affiliation>School of Medicine, The University of Texas Medical Branch, Galveston, Texas, 77555, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lindsay</LastName><ForeName>Sarah E</ForeName><Initials>SE</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, The University of Texas Medical Branch, Galveston, Texas, 77555, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zaidan</LastName><ForeName>Mohammed F</ForeName><Initials>MF</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, The University of Texas Medical Branch, Galveston, Texas, 77555, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Seashore</LastName><ForeName>Justin</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, The University of Texas Medical Branch, Galveston, Texas, 77555, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wexler</LastName><ForeName>Tamara L</ForeName><Initials>TL</Initials><AffiliationInfo><Affiliation>Department of Rehabilitation Medicine, NYU Grossman School of Medicine, New York, 10016, USA; Division of Endocrinology, Diabetes and Metabolism, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, 19104, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Masel</LastName><ForeName>Brent E</ForeName><Initials>BE</Initials><AffiliationInfo><Affiliation>Department of Neurology, The University of Texas Medical Branch, Galveston, Texas, 77555, USA; Centre for Neuro Skills, Bakersfield, California, 93313, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Urban</LastName><ForeName>Randall J</ForeName><Initials>RJ</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, The University of Texas Medical Branch, Galveston, Texas, 77555, USA. Electronic address: rurban@utmb.edu.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><DataBankList CompleteYN="Y"><DataBank><DataBankName>ClinicalTrials.gov</DataBankName><AccessionNumberList><AccessionNumber>NCT04860869</AccessionNumber></AccessionNumberList></DataBank></DataBankList><PublicationTypeList><PublicationType UI="D064888">Observational Study</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>10</Month><Day>08</Day></ArticleDate></Article><MedlineJournalInfo><Country>Ireland</Country><MedlineTA>Mol Cell Endocrinol</MedlineTA><NlmUniqueID>7500844</NlmUniqueID><ISSNLinking>0303-7207</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>9002-72-6</RegistryNumber><NameOfSubstance UI="D013006">Growth Hormone</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010865" MajorTopicYN="N">Pilot Projects</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011788" MajorTopicYN="N">Quality of Life</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016022" MajorTopicYN="N">Case-Control Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018450" MajorTopicYN="N">Disease Progression</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005221" MajorTopicYN="N">Fatigue</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013006" MajorTopicYN="N">Growth Hormone</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Biomarkers</Keyword><Keyword MajorTopicYN="N">Cognition</Keyword><Keyword MajorTopicYN="N">Depression</Keyword><Keyword MajorTopicYN="N">Fatigue</Keyword><Keyword MajorTopicYN="N">Gastrointestinal</Keyword><Keyword MajorTopicYN="N">Growth hormone</Keyword><Keyword MajorTopicYN="N">Long COVID</Keyword><Keyword MajorTopicYN="N">PASC</Keyword><Keyword MajorTopicYN="N">Quality of life</Keyword><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword><Keyword MajorTopicYN="N">Sleep</Keyword></KeywordList><CoiStatement>Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>7</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>9</Month><Day>4</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>9</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>12</Month><Day>17</Day><Hour>9</Hour><Minute>46</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>10</Month><Day>11</Day><Hour>0</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>10</Month><Day>10</Day><Hour>19</Hour><Minute>19</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37816478</ArticleId><ArticleId IdType="doi">10.1016/j.mce.2023.112071</ArticleId><ArticleId IdType="pii">S0303-7207(23)00222-8</ArticleId></ArticleIdList></PubmedData></PubmedArticle></PubmedArticleSet>